OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
June 04, 2021
Well-defined studies are crucial to effective process development.
June 02, 2021
Controlling certain atmospheric conditions in a closed NGI processing chamber can reduce bioburden without disinfectants.
May 01, 2021
As downstream bioprocessing improvements continue, efforts are underway to integrate downstream processes into continuous operations.
February 02, 2021
Connected, integrated bioprocessing enterprises with greater data analytics capabilities are coming.
February 01, 2021
A unified scale-up approach, as presented here, can be applied to any unit operation.
January 28, 2021
The launch of HiScreen Fibro PrismA, the company’s newest product for early mAb purification process development strengthens Cytiva’s new fiber-based Protein A platform.
January 05, 2021
The new facility, to be located in Boston, MA, will contain experimental and analytical equipment for viral vector and advanced therapy process development and will expand the CDMO’s manufacturing capacity.
January 02, 2021
Cell-culture optimization may see benefits from a synthetic biology-based approach that improves product titer, quality, and time.
The development of an innovative purification process simplifies downstream processing for biologics.
November 02, 2020
More collaboration and a knowledge-based approach, driven by better analytics and high-throughput system integration, are reducing the risk of failure.